Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.